Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 209 institutions that hold shares in the stock, with a total of 66.9 Million shares, which have been reported (via 13F filing form) to have a value of $3.03 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sg Americas Securities, LLC
|
Jan 17, 2025 Q4 2024 |
597,993
shares
|
$27 Million
0.07% of portfolio
|
Q4 2024
Added 4022.1%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
540,692
shares
|
$24.5 Million
0.0% of portfolio
|
Q4 2024
Added 1.52%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
528,207
shares
|
$23.9 Million
0.0% of portfolio
|
Q4 2024
Added 8.23%
|
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
520,114
shares
|
$23.5 Million
0.61% of portfolio
|
Q4 2024
Reduced 0.82%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
471,535
shares
|
$21.3 Million
0.0% of portfolio
|
Q4 2024
Added 5.24%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
460,617
shares
|
$20.8 Million
1.92% of portfolio
|
Q4 2024
Added 17.34%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
457,524
shares
|
$20.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 30.92%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
449,110
shares
|
$20.3 Million
0.0% of portfolio
|
Q4 2024
Added 6229.06%
|
|
|
University Of Wisconsin Foundation
Madison, WI |
Feb 13, 2025 Q4 2024 |
410,630
shares
|
$18.6 Million
8.3% of portfolio
|
Q4 2024
Reduced 3.12%
|
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
379,967
shares
|
$17.2 Million
0.08% of portfolio
|
Q4 2024
Added 29.92%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
371,844
shares
|
$16.8 Million
0.0% of portfolio
|
Q4 2024
Added 292.24%
|
|
|
Foresite Capital Management Vi LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
365,000
shares
|
$16.5 Million
4.52% of portfolio
|
Q4 2024
New holding
|
|
|
Emerald Mutual Fund Advisers Trust
|
Feb 14, 2025 Q4 2024 |
352,180
shares
|
$15.9 Million
0.67% of portfolio
|
Q4 2024
Reduced 15.18%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
343,729
shares
|
$15.5 Million
9.5% of portfolio
|
Q3 2024
Added 4.87%
|
|
|
Rheos Capital Works Inc.
|
Jan 24, 2025 Q4 2024 |
276,000
shares
|
$12.5 Million
0.43% of portfolio
|
Q3 2024
Added 27.78%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
275,074
shares
|
$12.4 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
273,811
shares
|
$12.4 Million
0.0% of portfolio
|
Q4 2024
Reduced 18.42%
|
|
|
Abrdn PLC
|
Jan 24, 2025 Q4 2024 |
269,782
shares
|
$12.2 Million
0.01% of portfolio
|
Q4 2024
Added 118.7%
|
|
|
Simplify Asset Management Inc.
New York, NY |
Feb 11, 2025 Q4 2024 |
264,677
shares
|
$12 Million
0.42% of portfolio
|
Q4 2024
Reduced 6.73%
|
|
|
Fred Alger Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
263,353
shares
|
$11.9 Million
0.04% of portfolio
|
Q4 2024
Reduced 2.32%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
262,295
shares
|
$11.9 Million
0.05% of portfolio
|
Q4 2024
Reduced 5.76%
|
|
|
B Group, Inc.
Dallas, TX |
Feb 14, 2025 Q4 2024 |
260,000
shares
|
$11.8 Million
4.42% of portfolio
|
Q4 2024
New holding
|
|
|
Cutter Capital Management, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
230,000
shares
|
$10.4 Million
2.62% of portfolio
|
Q4 2024
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
225,019
shares
|
$10.2 Million
0.0% of portfolio
|
Q4 2024
Added 3.43%
|
|
|
Great Lakes Advisors, LLC
Chicago, IL |
Feb 07, 2025 Q4 2024 |
193,384
shares
|
$8.74 Million
0.05% of portfolio
|
Q4 2024
New holding
|